| The purpose of this study is to investigate the benefit of preoperative chemotherapy in the non-small lung cancer (NSCLC) population. It will assess whether preoperative chemotherapy improves survival compared to surgery alone in previously untreated patients.
This study is for individuals with Stage IB, II, and selected IIIA non-small cell lung cancer. This is a Phase III trial. To learn about specific treatment guidelines, call the McGivney Center at the Hospital of Saint Raphael (203) 789-3545 or e-mail Pat Garofolo, M.S., B.S.N. study coordinator. You may also want to contact your physician for more information. |